Knowledge Distillery

Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine

BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a…

Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective…

Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in…

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome…

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Myalgia as a symptom at hospital admission by SARS-CoV-2 infection is associated to persistent musculoskeletal pain as long-term post-COVID sequelae:…

High-dimensional characterization of post-acute sequalae of COVID-19

In this article the authors examined vaccine effectiveness among health care workers at the Hadassah Hebrew University Medical Center (HHUMC), a…